Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSegro Regulatory News (SGRO)

Share Price Information for Segro (SGRO)

Share Price is delayed by 15 minutes
Get Live Data
712.80    -11.00 (-1.52%)
Bid:
712.80
Ask:
713.20
Spread: 0.40 (0.056%)
Market Cap: £9.64b
SGRO Live PriceLast checked at - London Stock Exchange

Intraday Segro Share Chart

Form 8.3 - SEGRO plc

4 Nov 2024 15:00

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Causeway Capital Management

LLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SEGRO plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

November 4, 2024 (dealing)

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Ordinary Shares

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

15,101,190

1.12%

 

 

(2) Cash-settled derivatives:

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

15,101,190

1.12%

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

Ordinary Shares

Sale

996

7.86 GBP

Ordinary Shares

 

 

 

Ordinary Shares

 

 

 

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None.

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

November 4, 2024

Contact name:

Kevin Hu

Telephone number*:

+1 (310) 231-6154

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241104073931/en/

Copyright Business Wire 2024

Date   Source Headline
2nd Jun 20264:00 pmRNSDirector/PDMR Shareholding
1st Jun 20263:35 pmRNSHolding(s) in Company
1st Jun 20263:30 pmRNSHolding(s) in Company
29th May 20264:20 pmRNSTotal Voting Rights
29th May 202612:00 pmRNSHolding(s) in Company
26th May 202611:00 amRNSBlock Admission Application
21st May 202612:00 pmRNSNotification of issuance of equity securities
14th May 202610:00 amRNSDirector/PDMR Shareholding
1st May 20263:10 pmRNSHolding(s) in Company
30th Apr 202611:58 amRNSDirector/PDMR Shareholding
23rd Apr 20261:39 pmRNSResult of AGM
23rd Apr 20267:00 amRNSTrading Update
15th Apr 20267:00 amRNSSELP JV PRICES €500 MILLION 3.875% UNSECURED BONDS
31st Mar 20262:30 pmRNSTotal Voting Rights
31st Mar 202611:00 amRNSDirector/PDMR Shareholding
27th Mar 202612:00 pmRNSDirector/PDMR Shareholding
26th Mar 202611:00 amRNSBlock Admission Application
19th Mar 20261:30 pmRNSHolding(s) in Company
16th Mar 20267:00 amRNSDATA CENTRE UPDATE
16th Mar 20267:00 amRNSDATA CENTRE UPDATE
13th Mar 202611:30 amRNSAnnual Report and Notice of Annual General Meeting
13th Mar 202611:30 amRNSAnnual Report and Notice of Annual General Meeting
26th Feb 202610:06 amRNSDirector/PDMR Shareholding
20th Feb 20267:00 amRNSResults for the year ended 31 December 2025
9th Feb 20262:00 pmRNSDirectorate change
22nd Jan 202612:00 pmRNSHolding(s) in Company
21st Jan 202612:00 pmRNSHolding(s) in Company
22nd Dec 20253:00 pmRNSHolding(s) in Company
22nd Dec 20253:00 pmRNSHolding(s) in Company
3rd Dec 202512:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSSEGRO SIGNS PRE-LET IN GERMANY
25th Nov 20253:30 pmRNSHolding(s) in Company
25th Nov 202511:00 amRNSHolding(s) in Company
27th Oct 20252:00 pmRNSHolding(s) in Company
21st Oct 20257:00 amRNSTrading Update
30th Sep 20252:00 pmRNSTotal Voting Rights
1st Sep 202512:00 pmRNSBlock listing Interim Review
29th Aug 20253:00 pmRNSTotal Voting Rights
31st Jul 20252:00 pmRNSDirector Declaration
31st Jul 20257:00 amRNSRESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025
30th Jun 20252:00 pmRNSTotal Voting Rights
12th Jun 20257:00 amRNSDirectorate Change
30th May 202512:00 pmRNSTotal Voting Rights
12th May 20251:00 pmRNSDirector/PDMR Shareholding
30th Apr 20251:41 pmRNSResult of AGM
30th Apr 20257:02 amRNSDirectorate Change
30th Apr 20257:00 amRNSTrading Update
29th Apr 20253:30 pmRNSDirector/PDMR Shareholding
15th Apr 20252:04 pmRNSHolding(s) in Company
15th Apr 202510:13 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.